2009
Top
Vol. 35
November November 2009 No. 7, p533
October October 2009 No. 6, p485
Therapeutic Approach for Unfit Older Patients in the Principal Tumor Types
August August 2009 No. 5, p391
June June 2009 No. 4, p309
May May 2009 No. 3, p193
April April 2009 No. 2, p97
February February 2009 No. 1, p1
2008
Top
Vol. 34
December December 2008 No. 8, p671
November November 2008 No. 7, p577
October October 2008 No. 6, p483
August August 2008 No. 5, p391
June June 2008 No. 4, p293
May May 2008 No. 3, p193
April April 2008 No. 2, p103
February February 2008 No. 1, p1
Supplement 2 2008,
Advances in Treatment of Metastatic Colorectal Cancer: 4 case-based Discussions
Supplement 1 2008,
2007
Top
Vol. 33
December December 2007 No. 8, p665
November November 2007 No. 7, p595
Adolescent Oncology
October October 2007 No. 6, p499
August August 2007 No. 5, p407
June June 2007 No. 4, p315
May May 2007 No. 3, p223
April April 2007 No. 2, p91
February February 2007 No. 1, p1
Supplement 1 2007,
German MDS Forum - From Nihilism to Algorithm
2006
Top
Vol. 32
December December 2006 No. 8, p583
November November 2006 No. 7, p491
October October 2006 No. 6, p407
August August 2006 No. 5, p325
June June 2006 No. 4, p243
May May 2006 No. 3, p157
April April 2006 No. 2, p65
February February 2006 No. 1, p1
Supplement 3 2006,
Supplement 2 2006,
Supplement 1 2006, p1
Supplement Role of biomarkers in optimizing patient therapy: Current practices and future therapies
2005
Top
Vol. 31
December December 2005 No. 8, p591
November November 2005 No. 7, p507
October October 2005 No. 6, p423
August August 2005 No. 5, p339
June June 2005 No. 4, p247
May May 2005 No. 3, p159
April April 2005 No. 2, p69
February February 2005 No. 1, p1
Supplement 4 2005,
Improving Outcomes for Patients in Breast Cancer
Supplement 3 2005, p1
Evidence and Experience: Zoledronic Acid in Cancer Induced Bone Disease Proceedings of a Satellite symposium held during the 5th International Conference on Cancer-induced Bone Disease, Davos, Switzerland, 20–24 March 2005
Supplement 2 2005,
Fulvestrant (‘Faslodex’) in Clinical Practice: International Experience from the Compassionate Use Programme
Supplement 1 2005, p1
Vth International Conference on Cancer-Induced Bone Disease
